{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:44:46Z","timestamp":1761489886605},"reference-count":12,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2016,7,2]]},"DOI":"10.3109\/10428194.2015.1106538","type":"journal-article","created":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T13:37:28Z","timestamp":1451914648000},"page":"1719-1722","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Antiviral prophylaxis for varicella zoster virus infections in patients with myeloma in the era of novel therapies"],"prefix":"10.3109","volume":"57","author":[{"given":"Benjamin W.","family":"Teh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon J.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon J.","family":"Worth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica A.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,1,4]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2014.01.004"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.107714"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.290"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.9641"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1951-6"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13532"},{"key":"CIT0007","unstructured":"National Cancer Institute (U.S.). Common Terminology Criteria for Adverse Events (CTCAE) version 4.03. Bethesda, MD: National Institutes of Health, National Cancer Institute; 2010."},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2550-3"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.865182"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1913-z"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-077644"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2015.1083858"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2015.1106538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T12:55:10Z","timestamp":1481806510000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428194.2015.1106538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,4]]},"references-count":12,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,12,24]]},"published-print":{"date-parts":[[2016,7,2]]}},"alternative-id":["10.3109\/10428194.2015.1106538"],"URL":"https:\/\/doi.org\/10.3109\/10428194.2015.1106538","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}